GlassScriptPhysician profile
Ashley A Ketcherside
NPI 1649443540
$2,363.93
in general payments reported to CMS, 2019-2025
34 companies · $35.16 in 2025
The $35.16 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $444 · 2021: $635 · 2022: $144 · 2023: $392 · 2024: $330 · 2025: $35.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.92 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $578.26 | 2019-2023 | Liletta |
| Astellas Pharma US INC | $223.81 | 2023-2024 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $199.49 | 2019-2021 | |
| Pfizer INC. | $99.51 | 2019-2023 | |
| Hologic Sales and Service, LLC | $99.48 | 2021-2024 | Aptima, Thinprep 2000 Processor, Coolseal Generator |
| Avion Pharmaceuticals | $92.77 | 2020-2022 | |
| Coopersurgical, INC. | $88.13 | 2021-2024 | Paragard T 380a |
| Biogen, INC. | $85.89 | 2024 | Zurzuvae |
| Amgen INC. | $84.02 | 2019-2022 | |
| Organon LLC | $83.67 | 2022-2025 | Nexplanon |
| Allergan, INC. | $70.82 | 2019-2020 | |
| Exeltis, USA INC. | $60.06 | 2021-2025 | Slynd |
| Therapeuticsmd, INC. | $59.97 | 2020-2021 | |
| Shield Therapeutics INC | $48.82 | 2024 | |
| Evofem Biosciences, INC. | $45.73 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $41.72 | 2019-2020 | |
| Agile Therapeutics, INC. | $38.70 | 2021-2022 | |
| Medtronic, INC. | $38.31 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.19 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $32.63 | 2019-2024 | Gardasil, Gardasil 9 |
| Davol INC. | $28.19 | 2023 | Arista Ah Flexitip |
| Amag Pharmaceuticals, INC. | $27.72 | 2019 | |
| Vertical Pharmaceuticals, LLC | $26.05 | 2019-2020 | |
| Gynesonics, INC. | $22.44 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Millicent US INC | $21.74 | 2024 | Intrarosa, Femring |
| Mayne Pharma Commercial LLC | $19.06 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.31 | 2021 | |
| Scynexis, INC. | $15.58 | 2022 | |
| Alexion Pharmaceuticals, INC. | $15.00 | 2019 | |
| Sumitomo Pharma America, INC. | $14.19 | 2023 | Myfembree |
| Minerva Surgical, INC | $14.02 | 2019 | |
| Zyla Life Sciences, INC. | $11.80 | 2020 | |
| Covidien LP | $11.46 | 2020 | |
| Myovant Sciences INC. | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Ketcherside listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.